Can Probiotics or Guided Imagery Change Cortisol?

Cortisol can respond to signals from the gut, the brain, exercise, sleep, illness, and the accumulated wear of life. That does not mean a probiotic capsule or guided-imagery recording can reliably "fix" it. Two randomized trials tested those very different routes into the stress system. Each found one interesting signal. Neither establishes a practical cortisol treatment.

The more novel trial used a strain related to microbes found in kefir. The larger trial used guided imagery in adolescents. Their results cannot be pooled or treated as proof from opposite ends of the gut-brain axis: they measured different cortisol patterns in very different people, and both results come with limits that change how much confidence they deserve.

A kefir-family strain produced a signal in a very small trial

In an eight-week double-blind randomized trial by Matsuura et al., 27 healthy Japanese men, about 23 years old on average, took daily Lactococcus lactis subsp. cremoris YRC3780 or placebo. Fourteen participants received the active supplement and 13 received placebo. The researchers tracked morning salivary cortisol and later exposed participants to the Trier Social Stress Test, a standardized laboratory stressor.

Morning cortisol attenuation appeared at week 6. The headline acute-stress result, however, came from a post-hoc subgroup: 15 of the 27 participants classified as cortisol responders. Forty minutes after the stress test, cortisol averaged 4.2 ± 4.4 nmol/L in eight active-supplement responders versus 7.6 ± 4.7 nmol/L in seven placebo responders (p=0.043, Mann-Whitney U test).

That number is worth reporting, but it is not a reliable basis for shopping advice. The subgroup was not pre-registered, included only 56% of those enrolled, and shrank an already tiny trial to eight versus seven people. Searching after the fact for the participants who show an effect makes false-positive findings more likely. The study did not report a confidence interval for that subgroup comparison in the available publication.

The biology is plausible, not proven. The authors discussed possible routes involving vagal 5-HT3 signaling, short-chain fatty acids, GABA, tryptophan-related signaling, and immune effects involving Foxp3-positive regulatory T cells. They analyzed gut microbiome composition, but did not link a specific microbial change to cortisol or measure the proposed pathway intermediates alongside cortisol outcomes. A plausible route on a diagram remains a hypothesis until human data connect its steps.

There is also a sobering precedent. A randomized trial reported by Wauters et al. notes that the HPA-blunting effect of Lactobacillus rhamnosus JB-1 in rodents, which depended on vagal signaling, did not reproduce in healthy humans after a socially evaluated cold pressor test. In that trial, a different strain, L. rhamnosus CNCM I-3690, reduced subjective academic stress, but subjective relief and cortisol output are not interchangeable.

A six-week exploratory trial of Bifidobacterium longum NCC3001 makes the same point in a different way: perceived stress fell, while cortisol was not a prominently positive endpoint. People can feel less stressed without a measurable change in the cortisol measure a study selected. Both outcomes can matter; neither substitutes for the other.

Guided imagery produced one small, hard-to-interpret cortisol change

The Imagine HEALTH trial tested a top-down approach. Researchers cluster-randomized 232 predominantly Latino adolescents aged 14 to 17 who were at metabolic risk, assigning schools to control, lifestyle-only, stress-reduction guided imagery, or lifestyle-behavior guided imagery. The intervention lasted 12 weeks. Researchers measured the cortisol awakening response (CAR) and diurnal cortisol slope (DCS) at baseline and follow-up.

Three of the four groups showed no significant between-group difference in CAR or DCS. That includes the stress-reduction guided-imagery arm, the arm most directly designed to affect stress physiology. No arm changed DCS, and no arm reduced perceived stress in the intent-to-treat analysis.

Only the lifestyle-behavior guided-imagery group differed from control: CAR increased modestly in the intent-to-treat analysis (p=0.045; Cohen's d=0.24). Among participants who adhered to the intervention, CAR increased with d=0.37 (p=0.03), while perceived stress fell with d=-0.66. The publication does not provide a confidence interval for these estimates in the information available here.

This was a statistically significant result by the usual p<0.05 convention, but its clinical meaning is unresolved. It was an increase in CAR, not a reduction, and a higher or lower CAR does not carry one universal health meaning. A 2024 systematic review and meta-analysis found that links between diurnal cortisol measures, stress reactivity, and recovery depend on context and are often non-linear.

The result also sits close to the conventional significance threshold. The trial had four arms and assessed CAR, DCS, and awakening cortisol; no multiple-comparison correction was reported. The adherent-participant analysis may partly reflect who was able or motivated to stick with the program, rather than the program alone. Since lifestyle-behavior guided imagery combined behavior-change content with imagery, it cannot isolate guided imagery as the cause of the CAR change.

Why the two trials do not answer the same question

The probiotic study tested acute cortisol reactivity after laboratory stress in young, healthy men. Imagine HEALTH tested daily cortisol patterns in adolescents at metabolic risk. One randomized individuals for eight weeks; the other randomized schools for 12 weeks. The first has a small, post-hoc subgroup result; the second has a small, borderline result in one of four arms and a null result in its dedicated stress-reduction arm.

Those differences matter because cortisol varies substantially between people. Chronic stress, sex, and early adversity can shape baseline HPA-axis activity and daily cortisol rhythms. A 2025 systematic review and meta-analysis linked childhood adversity with higher afternoon cortisol, flatter diurnal slope, blunted stress reactivity, and higher hair cortisol in children and adolescents, though the effects varied by adversity and developmental stage. A separate longitudinal study also linked the timing and severity of adversity with later cortisol patterns.

These are not minor background details. The YRC3780 study enrolled only men, so it cannot establish the same effect in women. The adolescent trial involved a population whose prior stress exposures and baseline physiology may affect response. Neither finding tells us who should choose a probiotic over guided imagery for cortisol.

The gut-cortisol link is real enough to study, not settled enough to sell

Human observational research supports further work. A 2025 community study associated gut microbiota composition with daily cortisol indices and heart-rate variability. Association does not show that changing one microbe changes cortisol, much less that a commercial fermented food reproduces a trial result. Commercial kefir contains variable, unstandardized microbial mixtures; it is not equivalent to YRC3780.

Probiotic evidence is especially strain-specific. A semi-randomized trial in 262 Ivorian children tested a composite probiotic food and measured salivary cortisol, but its multi-strain design cannot confirm or refute a YRC3780 effect. The field needs larger, pre-registered trials with clinically meaningful endpoints, measured mechanisms, and independent replication.

For a low-risk experiment, healthy adults may reasonably eat fermented foods because they enjoy them or want dietary variety. They should not buy kefir expecting a demonstrated cortisol effect. Guided imagery may help some people feel calmer, and it carries little downside for most people, but the best trial described here did not show that stress-reduction imagery reliably changed cortisol.

If cortisol regulation is the goal, physical activity has a stronger evidence base than either focal intervention, though it is hardly a precision dial. A 2023 meta-analysis of physical activity and cortisol found a small average association with diurnal cortisol slope (r=-0.043; 95% CI, -0.080 to -0.004), with substantial variation across studies. The modest size is the lesson: even better-studied behaviors tend to produce small and heterogeneous cortisol effects.

Two trials show that gut-directed and mind-body interventions can generate cortisol signals under specific conditions. They do not show that either approach reliably normalizes cortisol, identifies likely responders, or improves health through cortisol change.

The gut-brain-HPA axis deserves serious research. It does not yet justify a decision tree that assigns people to a probiotic strain or a guided-imagery program based on cortisol promises. The most honest practical choice is simpler: use low-risk habits you can sustain, reserve medical evaluation for symptoms or suspected endocrine disease, and treat single-study biomarker findings as leads rather than answers.